Louis holds a Ph.D. in Life Sciences from the University of Reading and L'Institut Agro Rennes-Angers. This PhD degree provided him with expertise in protein functions, structures, interactions, and roles within biological systems.
Having found his footing in Scotland, Louis joined RoukenBio’s bioanalytical department in 2020. He has a particular interest in potency assay and Surface Plasmon Resonance (SPR), covering aspects such as development, qualification, and sample testing.
Resources
Research Posters
24 March 2026
|4 min read
Surface Plasmon Resonance (SPR) plays a vital role across drug discovery and development, from early candidate screening to detailed product characterisation, including antigen and Fc‑receptor interactions. For biosimilar development, ensuring that SPR methods used for comparative binding analyses are rigorously qualified is essential for regulatory acceptance. This research poster outlines the qualification of multiple SPR assays designed to measure Fcγ receptor, FcRn, and antigen binding to a monoclonal antibody.
Research Posters
4 November 2025
|5 min read
Anti-drug antibodies (ADAs) can derail a drug’s success before it ever reaches patients. In this study, we built a sensitive SPR-based assay to detect pre-existing ADAs in treatment-naïve serum helping drug developers make smarter, safer choices early on. From chip selection to control validation, here’s how we tackled the challenge.
Insights
22 April 2024
|6 min read
The Neonatal Fc Receptor (FcRn) shows promising therapeutic potential in autoimmunity and other conditions.
